The California stem cell institute’s plan to profit from the research it funds is going to cost it.
The Wisconsin Alumni Research Foundation said it is approaching licensing talks with the California Institute for Regenerative Medicine as if the organization were a commercial entity, since it plans to capture revenue from the commercialization of the research it funds. The institute, created by voters in 2004, will oversee $3 billion earmarked for stem cell research